A Quick Summary of the COVID-19 Literature
Medscape,
Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
The full data from the remdesivir trial by the National Institutes of Health (NIH) has finally been released, weeks after…
Les études sur le remdesivir, un antiviral envisagé comme traitement de la Covid-19, se multiplient.
The latest news is positive, but... For some reason, remdesivir seems to get more negative press than data supports.
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
We explain some of the medications being tested as potential treatments for Covid-19 coronavirus, and what this could mean for…
A successful vaccine for prevention of SARS-CoV-2 infection will probably need to incorporate T-cell epitopes to induce a long-te…
Als erstes Medikament gegen Covid-19 soll Remdesivir in der EU bald vorläufig zugelassen werden.
Tyler Durden Wed, 05/20/2020 - 16:45 At a moment in time when narrative-following "scientists" are lauded like unquestionably…
Mesoblast (NASDAQ: MESO ) is an Australian company at the forefront of regenerative therapies with its lead product Remestemcel-L…
At a moment in time when narrative-following "scientists" are lauded like unquestionably omniscient supreme beings enabling dumb…
Una nota dell'Agenzia italiana del farmaco ai medici: "Prima di avviare nuovi test, assicuratevi che ci siano abbastanza malati…
Anyone can publish on Medium per our Policies, but we don’t fact-check every story.
On April 29, the National Institutes of Health (NIH) announced that in a placebo-controlled trial of patients with advanced…
Una nota dell'Agenzia italiana del farmaco ai medici: "Prima di avviare nuovi test, assicuratevi che ci siano abbastanza malati…
Eine Lösung im Kampf gegen Covid-19 liegt womöglich ganz nah: Im Blut von Menschen, die die Krankheit überstanden haben …
Braunschweig. In der Stimme des Professors liegt Vorsicht. Er will keine falschen Hoffnungen wecken.
Braunschweig. In der Stimme des Professors liegt Vorsicht. Er will keine falschen Hoffnungen wecken.
Braunschweig. In der Stimme des Professors liegt Vorsicht. Er will keine falschen Hoffnungen wecken.
Infectious Disease > COVID-19 Data remain sparse, but a few risks are emerging The adverse event profile for remdesivir as a…
What your doctor is reading on Medscape.com: MAY 18, 2020 -- Since March 25, two HIV clinical fellows, Eric Meyerowitz, MD, and…
Private companies, governments and research institutes are holding news conferences to report potential breakthroughs that…
Direct • L’Europe poursuit sa levée des restrictions imposées en mars en raison du coronavirus.
Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
1. Adults with severe COVID-19 treated with remdesivir had numerically faster time to clinical improvement compared to controls…
Candidate: Remdesivir (GS-5734) Type: Nucleotide prodrug Status: Gilead said May 15 it licensed remdesivir to five generic drug…
By Liz Szabo of Kaiser Health News Although scientists and stock markets have celebrated the approval for emergency use of…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
By LIZ SZABO May 17, 2020 04:00 AM, Although scientists and stock markets have celebrated the approval for emergency use of…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Kaiser Health News Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Drug companies are investing billions to develop effective drugs and vaccines to help end the pandemic.
By Liz Szabo, Kaiser Health News Although scientists and stock markets have celebrated the approval for emergency use of…
With so many parts of the body under siege at once, scientists say, improving survival rates will require multiple routes of…
The race to find treatments and other therapeutic options such as vaccines for COVID-19 is on, and success is still a long way…
Got a TV Licence? You need one to watch live TV on any channel or device, and BBC programmes on iPlayer.
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Aunque los científicos y los mercados bursátiles han celebrado la aprobación para uso de emergencia del remdesivir para tratar…
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
_.
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure…
Hak atas foto ULRICH PERREY/Getty Badan Pengawas Obat dan Makanan Amerika Serikat (FDA) telah menandatangani perjanjian dengan…
Une nouvelle étude prépubliée au sujet de la chloroquine fait parler d'elle sur les réseaux sociaux.
Копирайт изображения Getty Images У США зупинили клінічні випробування ремдесивіру - антивірусного препарату, який до останнього…
The extreme shortage of the COVID-19 drug remdesivir means that hospitals are being forced to make tough decisions about whom…
В США остановлены клинические испытания ремдесивира - антивирусного препарата, который до последнего времени считался наиболее пе…
Правообладатель иллюстрации Getty Images В США остановлены клинические испытания ремдесивира - антивирусного препарата, который д…
OXFORD: Rivals Usain Bolt and Justin Gatlin trash-talked each other before the 2016 Olympics, with Bolt calling Gatlin “old man”…
Whether it works remains undetermined, but many are optimistic about an experimental drug approved for emergency treatment of…
An analysis of more than 1,000 COVID-19 patients in New York found no noticeable benefit in using hydroxychloroquine to treat…
According to recent reports by WHO, there are 4,256,123 COVID-19 cases around the world, with 287,336 deaths.
Governor Ron DeSantis recently said the COVID-19 figures have improved statewide.
Rivals Usain Bolt and Justin Gatlin trash-talked each other before the 2016 Olympics, with Bolt calling Gatlin “old man”, and…
– By Jeremy Howick, Director of the Oxford Empathy Programme, University of Oxford Rivals each other before the 2016 Olympics…
Rivals Usain Bolt and Justin Gatlin trash-talked each other before the 2016 Olympics, with Bolt calling Gatlin “old man”, and…
Rivals Usain Bolt and Justin Gatlin trash-talked each other before the 2016 Olympics, with Bolt calling Gatlin “old man”, and…
Rivals Usain Bolt and Justin Gatlin trash-talked each other before the 2016 Olympics, with Bolt calling Gatlin “old man”, and…
It's been hailed as "highly significant" — though not quite the "knockout" treatment for coronavirus that scientists had hoped…
It's been hailed as "highly significant" — though not quite the "knockout" treatment for coronavirus that scientists had hoped…
Share on Pinterest More than 1.2 million people in the U.S. have tested positive for COVID-19.
It wasn’t exactly what you’d call a triumph for science. During an April coronavirus press briefing, President Trump tossed out…
Got a TV Licence? You need one to watch live TV on any channel or device, and BBC programmes on iPlayer.
_.
Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
Last week saw three studies with seemingly contradictory results about the antiviral drug remdesivir, culminating in the Food…
Sur le live Coronavirus A son tour, le Japon approuve le médicament remdesivir contre le Covid-19 Traitement.
Got a TV Licence? You need one to watch live TV on any channel or device, and BBC programmes on iPlayer.
El diario El Tiempo y la revista Semana han publicado contenidos patrocinados por el laboratorio español Sesderma donde dice…
Editor's Note: We’ve removed our paywall from this article so you can access vital coronavirus content.
Corona moet uitwoeden, klonk het al snel: een virusziekte kun je niet genezen. Of wel? Achter de schermen is de zoektocht in…
A FDA, agência que regula os remédios nos Estados Unidos, aprovou em caráter emergencial o uso do antiviral remdesivir no…